Clinical Trial Details

EORTC-06083-LG

Back to Clinical Trials Database

Clofarabine added to prephase and consolidation therapy in acute lymphoblastic leukemia in adults. A prospective randomized trial.

Study documentation

Trial Status Closed to Patient Entry
Dates Date of activation: 19-Dec-2011
Date Step1 close: 10-Nov-2016
Data management at EORTC No
Design Phase 2-3
Randomized open label
Targeted Sample size EORTC Groups: 15 - All Groups: 340
Treatment Drug
Mercaptopurine, Tioguanine, Clofarabine, Cytarabine, Daunorubicin, Doxorubicin, Etoposide, Leucovorin, Methotrexate, Prednisolone, Prednisone, Vinblastine, Vincristine, Vindesine, Dexamethasone
Study Staff Jean-Pierre Marie (Study Coordinator) , Assistance Publique - Hopitaux de Paris - Hopital Saint Antoine, Paris
Claire Gandilhon (Clinical Operations Assistant) , EORTC Headquarters, Brussels
Liv Meert (Data Manager) , EORTC Headquarters, Brussels
Stefan Suciu (Statistician) , EORTC Headquarters, Brussels
Laurens Vinckier (Pharmacovigilance Manager) , EORTC Headquarters, Brussels
Gaetan de Schaetzen (Senior Clinical Operations Manager) , EORTC Headquarters, Brussels
Type of cancer Acute Lymphocytic Leukemia
Participating groups EORTC Leukemia Group
Hemato-Oncologie Volwassenen Nederland
Recruiting centers Assistance Publique - Hopitaux de Paris - Hopital Saint Antoine (Paris, France)
Protocol summary http://clinicaltrials.gov/ct/show/
NCT number
EudraCT 2008-005798-36
Financial Support EORTC Group